Where the paraquat litigation stands today
The paraquat Parkinson's litigation is running on two active tracks. The federal MDL 3004 in the Southern District of Illinois consolidates thousands of cases before Judge Nancy Rosenstengel and continues to administer claims under the Syngenta master settlement framework announced in 2024. The Philadelphia Complex Litigation Center hosts a parallel state-court mass tort of roughly 1,799 active cases before Judge Joshua Roberts, and continues to grow as opt-outs and new claimants file there under Pennsylvania's consent-by-registration jurisdiction.
The January 2026 bellwether — and what it re-priced
The first Philadelphia bellwether was scheduled for trial in January 2026. It settled confidentially on the courthouse steps minutes before jury selection. The dollar figure is sealed. The meaning is not: defendants pay courthouse-steps premiums to avoid a hostile Philadelphia verdict because a single adverse verdict becomes Exhibit A across the entire docket. Expect upward pressure on offers, and expect more cases to settle before trial as the next bellwether approaches.
Opt-outs and the shift to state court
A meaningful share of MDL-eligible claimants have opted out of the Syngenta settlement framework to pursue Philadelphia state-court claims. The catalyst was the U.S. Supreme Court's October 2025 decision to decline review of Syngenta's challenge to Pennsylvania's consent-by-registration jurisdiction under Mallory v. Norfolk Southern. Out-of-state claimants exposed in California, Iowa, Illinois, Texas, Florida, and other states can now file in Philadelphia subject to attorney eligibility analysis. For most claimants with strong facts, PA state court is the highest-value forum available.
Syngenta halting paraquat production
In 2025 Syngenta announced it would wind down paraquat manufacturing. That does not end pending litigation, cap liability, or extinguish existing claims. In practice, exit announcements typically increase settlement pressure by clarifying the historical exposure record and reducing the defendant's incentive to preserve the product's regulatory standing.
What claimants should expect on settlement amounts
Public reporting on the Syngenta MDL framework describes a points-based allocation grid. Individual awards run from the low tens of thousands for weak fact patterns up to seven figures for the strongest cases. The four biggest levers are:
- Exposure duration and intensity — years handling paraquat, whether as mixer/loader/applicator versus incidental contact.
- Age at diagnosis — younger diagnoses generally allocate higher.
- Symptom severity and disease progression — Hoehn & Yahr staging, functional impairment, care needs.
- Documentation — employer records, applicator license, supplier invoices, medical records from a movement disorder specialist.
Philadelphia state-court outcomes are widely expected to run higher on average than MDL awards for equivalent fact patterns — the structural reasons are covered on the Pennsylvania paraquat lawsuit page.
Typical timeline from filing to payout
- Case review (week 0): 15–30 minute free intake by phone.
- Records collection (weeks 1–8): medical, employment, applicator license, supplier records.
- Filing (weeks 4–12): complaint filed in the appropriate forum — MDL or Philadelphia CLC.
- Case management and discovery (months 3–18): plaintiff fact sheet, defense fact sheet, expert designations.
- Settlement or trial (months 12–36): most cases resolve in a settlement tranche; a small number try.
- Claim administration and lien resolution (60–180 days): Medicare, Medicaid, and ERISA lien resolution before disbursement.
Deadlines you should not miss
Statute of limitations defenses are the most common reason paraquat claims are lost before trial. Pennsylvania's two-year clock runs from accrual under 42 Pa.C.S. § 5524. Wrongful death and survival claims under 42 Pa.C.S. §§ 8301–8302 have their own two-year window from date of death. Other states range from one to six years. If you have a diagnosis — or a family member did — start the review now, even if you are not sure you want to file. Check Pennsylvania eligibility →